注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶？ 登入
Moderna Inc (MRNA)
NASDAQ
| 代號 | 交易所 | 貨幣 | ||
|---|---|---|---|---|
| MRNA | NASDAQ | USD | 即時 | |
| MRNA | 墨西哥 | MXN | 延遲 | |
| MRNA | 米蘭 | EUR | 即時 | |
| 0QF | TradeGate | EUR | 延遲 | |
| 0QF | 法蘭克福 | EUR | 延遲 | |
| MRNA | 維也納 | EUR | 即時 | |
| MRNA_KZ | KASE | USD | 延遲 | |
| MRNA | 利馬 | USD | 延遲 |
從投資組合中新增/移除
新增至觀察名單
Moderna
107.97
+1.79
+1.69%
Moderna Inc公司檔案
在此獲得Moderna Inc的詳細檔案，包括公司業務、主要管理層介紹、員主資料和位址聯繫方式。
Moderna Inc是一家生物技術公司。該公司專注於開發信使核糖核酸（mRNA）療法和疫苗。該公司獨立並與其戰略合作夥伴一起開發傳染病、免疫腫瘤學、罕見病、自身免疫和心血管疾病的治療藥物和疫苗。 mRNA藥物旨在引導人體細胞產生細胞內、膜或分泌蛋白，這些蛋白具有治療或預防作用，有可能解決一系列疾病。該公司的產品包括Spikevax、Moderna COVID-19疫苗（mRNA-1273）、一種針對BA.1 Omicron變體的二價疫苗，結合Spikevax（mRNA-1273.214），以及針對BA.4/BA.5的二價疫苗Omicron變體結合Spikevax (mRNA-1273.222)。該公司在其48個開發項目中擁有45個開發候選人的開發管道，其中38個正在進行臨床研究。
聯絡資訊
地址
200 Technology Square
Cambridge, 02139
United States
Cambridge, 02139
United States
電話
617 714 6500
傳真
617 649 3910
主要管理層
| 名稱 | 年齡 | 成立於 | 主旨 |
|---|---|---|---|
| Sandra J. Horning | 73 | 2020 | Independent Director |
| Noubar B. Afeyan | 60 | 2010 | Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board |
| Stephane Bancel | 50 | 2011 | CEO & Director |
| Ron Eydelloth | - | - | Member of Scientific Advisory Board |
| Rachel Green | - | - | Member of Scientific Advisory Board |
| Paul L. Sagan | 64 | 2018 | Independent Non Executive Director |
| Ralph Weissleder | - | - | Member of Scientific Advisory Board |
| Paula T. Hammond | 59 | - | Member of Scientific Advisory Board |
| Michael Diamond | - | - | Member of Scientific Advisory Board |
| Stephen A. Berenson | 62 | 2017 | Independent Non Executive Director |
| Melissa J. Moore | - | 2016 | Member of Scientific Advisory Board |
| Jack W. Szostak | - | 2014 | Chairman of Scientific Advisory Board |
| Richard C. Willson | - | 2014 | Member of Technology Advisory Board |
| Robert S. Langer | 75 | 2010 | Independent Non Executive Director & Member of Scientific Advisory Board |
| Fred E. Regnier | - | 2014 | Member of Technology Advisory Board |
| John G. Aunins | 63 | 2014 | Member of Technology Advisory Board |
| James R. Swartz | - | 2014 | Member of Technology Advisory Board |
| Elizabeth G. Nabel | 72 | 2021 | Independent Director |
| Elizabeth Edith Tallett | 74 | 2020 | Independent Director |
| Ulrich H. von Andrian-Werburg | - | - | Member of Scientific Advisory Board |
| Francois Nader | 67 | 2019 | Independent Non Executive Director |
在留言中加插圖表
確認封鎖
你確定要封鎖 %USER_NAME%？
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖，必須等候 48 小時後才可再次封鎖。
舉報此評論
我覺得這個評論是:
評論被加標記
謝謝！
您的報告已被發送到我們的版主審核